Showing all posts written by Daniel Fullerton

Daniel Fullerton
Daniel Fullerton

Daniel C. Fullerton is an associate in the firm’s Orange County office.

Mr. Fullerton specializes in intellectual property law, with a focus on patent preparation and prosecution in the medical device field. During law school, Mr. Fullerton worked as a clinical intern for the USC Intellectual Property and Technology Law Clinic, where he worked on various copyright and other intellectual property matters for individuals and non-profits.


Boston Scientific Files Second IPR Petition Against UAB Patent

Boston Scientific Files Second IPR Petition Against UAB Patent

Boston Scientific Corporation (“Boston Scientific”) filed a petition with the Patent Trial and Appeal Board on April 10, 2015 requesting inter partes review of U.S. Patent No. 6,266,563 (“the ’563 Patent”).  The petition

Inter Partes Review Requested for MiMedx Tissue Graft Patent

Inter Partes Review Requested for MiMedx Tissue Graft Patent

Tissue Transplant Technology Ltd. and Human Biologics of Texas Ltd. (“the Petitioners”) recently filed a petition with the Patent Trial and Appeal Board requesting inter partes review of U.S. Patent No. 8,597,687 (“the

Boston Scientific Files Petitions for Inter Partes Review of Three VSI Patents

Boston Scientific Files Petitions for Inter Partes Review of Three VSI Patents

On May 15 and 16, 2014, Boston Scientific Corporation and Boston Scientific Scimed, Inc. (collectively, “Boston Scientific”) filed a total of five petitions with the Patent Trial and Appeal Board requesting inter partes review

Medtronic Files for Inter Partes Review of Endotach Intravascular Stent Patent

Medtronic Files for Inter Partes Review of Endotach Intravascular Stent Patent

On April 25, 2014, Medtronic, Inc. and Medtronic Vascular, Inc. (“Medtronic”) filed a second petition (the ’695 Petition) with the Patent Trial and Appeal Board requesting inter partes review of U.S. Patent No. 5,593,417

Medtronic Files for Inter Partes Review of Bosch Healthcare Patent

Medtronic Files for Inter Partes Review of Bosch Healthcare Patent

On February 14, 2014, Medtronic, Inc. (“Medtronic”) filed a petition with the Patent Trial and Appeal Board requesting inter partes review of U.S. Patent No. 7,587,469 (“the ’469 Patent”).

The ’469 Patent is entitled “Audio

Indiana University Research and Technology Corporation Files Patent Infringement Lawsuit

Indiana University Research and Technology Corporation Files Patent Infringement Lawsuit

Indiana University Research & Technology Corporation (IURTC) filed a lawsuit against AngioDynamics, Inc. alleging infringement of U.S. Patent No. 6,719,717 (“the ‘717 Patent”).  The lawsuit was filed on December

Mirowski Family Ventures Files Lawsuit Against Boston Scientific

Mirowski Family Ventures Files Lawsuit Against Boston Scientific

Last week, Mirowski Family Ventures, LLC filed a lawsuit against Boston Scientific Corp. and its wholly-owned subsidiaries Cardiac Pacemakers, Inc., Guidant LLC, and Guidant Sales LLC. According to the complaint, the defendants breached

TriVascular Files for Inter Partes Review of Inflatable Intraluminal Stent Patent

TriVascular Files for Inter Partes Review of Inflatable Intraluminal Stent Patent

On August 5, 2013, TriVascular, Inc. filed a petition with the Patent Trial and Appeal Board requesting inter partes review of U.S. Patent No. 6,007,575 owned by named inventor Dr. Shaun L.W. Samuels.

The ’575 Patent is entitled “Inflatable

NuVasive Files for Inter Partes Review of Warsaw Orthopedic’s Spinal Implant Patent

NuVasive Files for Inter Partes Review of Warsaw Orthopedic’s Spinal Implant Patent

On June 27, 2013, NuVasive, Inc. filed two petitions with the Patent Trial and Appeal Board requesting inter partes review of Warsaw Orthopedic, Inc.’s U.S. Patent No. 8,444,696.

The ’696 Patent is entitled “Anatomic Spinal

Respironics Files for Inter Partes Review of ZOLL Medical’s Patient Monitoring Patent

Respironics, Inc., a subsidiary of Koninklijke Philips N.V., filed a petition last Friday with the Patent Trial and Appeal Board requesting inter partes review of ZOLL Medical Corporation’s U.S. Patent No. 6,681,003 to Linder

Carticept Medical Receives FDA Clearance For Computer-Controlled Injection System

Carticept Medical, Inc. announced today that it received 510(k) clearance from the United States Food and Drug Administration for its Navigator® Delivery System (DS), a computer-controlled injection system.  The press release states

Harbor MedTech Announces Market Launch of Architect™ Collagen Matrix

Harbor MedTech, Inc., announced today FDA clearance for its first product, Architect™, which it describes as an advanced collagen matrix for treatment of skin wounds.  In the press release, Harbor MedTech President and Founder Jerry

St. Jude Medical Announces First Patient Implant in Clinical Trial of Cardiac Plug

St. Jude Medical, Inc. issued a press release today announcing the first patient implant in a clinical trial of the company’s AMPLATZER™ Cardiac Plug (ACP), a device designed to prevent stroke in patients with non-valvular atrial

AngioLight Forms Partnership With MTIA

Interventional cardiology medical device company AngioLight announced today that it has formed a partnership with Medical Technologies Innovation Asia (MTIA).  According to AngioLight’s press release, MTIA will perform